中文久久久字幕|亚洲精品成人 在线|视频精品5区|韩国国产一区

歡迎來(lái)到優(yōu)發(fā)表網(wǎng),期刊支持:400-888-9411 訂閱咨詢(xún):400-888-1571股權(quán)代碼(211862)

購(gòu)物車(chē)(0)

期刊大全 雜志訂閱 SCI期刊 期刊投稿 出版社 公文范文 精品范文

Annual Review Of Cancer Biology-series SCI/SCIE

Annual Review Of Cancer Biology-series

  • ISSN:2472-3428
  • ESSN:2472-3428
  • 國(guó)際標(biāo)準(zhǔn)簡(jiǎn)稱(chēng):ANNU REV CANCER BIOL
  • 出版地區(qū):UNITED STATES
  • 出版周期:1 issue/year
  • 研究方向:無(wú)
  • 出版年份:2017
  • 語(yǔ)言:English
  • 是否OA:未開(kāi)放
  • 學(xué)科領(lǐng)域

    無(wú)
  • 中科院分區(qū)

    無(wú)
  • JCR分區(qū)

    無(wú)
  • IF影響因子

    5.413
  • 是否預(yù)警

期刊簡(jiǎn)介

Journal Title:Annual Review Of Cancer Biology-series

Annual Review Of Cancer Biology-series reviews a range of topics in cancer research that represent important and emerging areas in the field. With recent advances in our understanding of the fundamental mechanisms of cancer development and the increasing translation of these findings into the clinic in the form of targeted therapies for the disease, the Annual Review Of Cancer Biology-series is divided into three main themes: Cancer Cells Biology, tumorigenesis and cancer progression, and translational cancer science.

中文簡(jiǎn)介

《癌癥生物學(xué)年度評(píng)論》系列回顧了癌癥研究中的一系列主題,這些主題代表了該領(lǐng)域的重要和新興領(lǐng)域。隨著我們對(duì)癌癥發(fā)展基本機(jī)制的理解不斷取得進(jìn)展,以及這些發(fā)現(xiàn)越來(lái)越多地以針對(duì)該疾病的靶向療法的形式轉(zhuǎn)化為臨床,《癌癥生物學(xué)年度評(píng)論》系列分為三個(gè)主要主題:癌細(xì)胞生物學(xué)、腫瘤發(fā)生和癌癥進(jìn)展以及轉(zhuǎn)化癌癥科學(xué)。

期刊點(diǎn)評(píng)

Annual Review Of Cancer Biology-series創(chuàng)刊于2017年,由ANNUAL REVIEWS出版商出版,影響因子指數(shù)5.413,該期刊近期沒(méi)有被列入國(guó)際期刊預(yù)警名單,廣大學(xué)者值得一試。

其他數(shù)據(jù)

是否OA開(kāi)放訪(fǎng)問(wèn): h-index: 年文章數(shù):
未開(kāi)放 -- --
Gold OA文章占比: 2021-2022最新影響因子(數(shù)據(jù)來(lái)源于搜索引擎): 開(kāi)源占比(OA被引用占比):
-- -- 0.59...
研究類(lèi)文章占比:文章 ÷(文章 + 綜述) 期刊收錄: 中科院《國(guó)際期刊預(yù)警名單(試行)》名單:
-- SCI、SCIE

歷年引文指標(biāo)和發(fā)文量:

發(fā)文統(tǒng)計(jì)

2023-2024國(guó)家/地區(qū)發(fā)文量統(tǒng)計(jì):

國(guó)家/地區(qū) 數(shù)量
USA 57
Canada 3
England 3
Australia 2
GERMANY (FED REP GER) 2
Netherlands 2
Scotland 2
Belgium 1
France 1
Israel 1

2023-2024機(jī)構(gòu)發(fā)文量統(tǒng)計(jì):

機(jī)構(gòu) 數(shù)量
HARVARD UNIVERSITY 12
UNIVERSITY OF CALIFORNIA SYSTEM 9
MASSACHUSETTS INSTITUTE OF TECHN... 8
MEMORIAL SLOAN KETTERING CANCER ... 7
DANA-FARBER CANCER INSTITUTE 6
HOWARD HUGHES MEDICAL INSTITUTE 5
CORNELL UNIVERSITY 4
MASSACHUSETTS GENERAL HOSPITAL 4
STANFORD UNIVERSITY 4
BRIGHAM & WOMEN'S HOSPITAL 3

近年引用統(tǒng)計(jì):

期刊名稱(chēng) 數(shù)量
NATURE 207
CELL 206
SCIENCE 148
P NATL ACAD SCI USA 121
CANCER RES 86
BLOOD 80
CANCER DISCOV 73
NEW ENGL J MED 71
CANCER CELL 68
NAT MED 63

近年被引用統(tǒng)計(jì):

期刊名稱(chēng) 數(shù)量
CANCERS 11
INT J MOL SCI 11
SCI REP-UK 6
FRONT IMMUNOL 5
FRONT ONCOL 5
P NATL ACAD SCI USA 5
CELL 4
DNA REPAIR 4
FRONT CELL DEV BIOL 4
FRONT GENET 4

近年文章引用統(tǒng)計(jì):

文章名稱(chēng) 數(shù)量
The Fanconi Anemia Pathway in Ca... 54
The Hallmarks of Ferroptosis 47
Homology-Directed Repair and the... 30
Cancer Immunotherapy: Beyond Che... 29
Natural Killer Cells in Cancer I... 21
Emerging Topics on Disseminated ... 15
Lineage Plasticity in Cancer Pro... 14
Deciphering Human Tumor Biology ... 12
MiT/TFE Family of Transcription ... 12
Roles of the cGAS-STING Pathway ... 12

免責(zé)聲明

若用戶(hù)需要出版服務(wù),請(qǐng)聯(lián)系出版商:Annu. Rev. Canc. Biol.。